VIM and Alzheimer disease: The first five are evidence-based biomarker candidates according to DisGeNET’s AD database, whereas vimentin, a phenotypic marker of glial cells and endothelial cells, is also a classical marker of astrogliosis, a phenomenon which is tightly related with neuronal loss.